IRIDEX Corporation Overview
Pro stress-test →IRIDEX Corporation is an ophthalmic medical technology company that provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles including the Cyclo G6 for glaucoma treatment and IQ 532/577 systems for retinal disorders, as well as OcuLight systems for diabetic retinopathy and retinal detachments.
Strategic Profile
Pro stress-test →IRIDEX's business model combines capital equipment sales with recurring revenue from consumables and service contracts, positioning it within a growing but competitive medtech niche. The company generates high-margin (80%) recurring revenue through sales of consumable products (predominantly single-use probes) as well as repair, service, and extended service contracts for laser systems. In April 2026, IRIDEX announced a new partnership with EyeProGPO, an ophthalmology-focused group purchasing organization.
Competitive Landscape
Pro stress-test →IRIDEX competes in the specialized ophthalmic laser systems market against larger medical device manufacturers and focused laser technology competitors. The company differentiates through its MicroPulse technology platform and established installed base of laser systems generating recurring consumables revenue. Competitive dynamics include both direct laser system manufacturers and alternative treatment modalities for glaucoma and retinal diseases.
Industry Context
IRIDEX Corporation operates in Ophthalmic laser systems and surgical devices.
Key facts
Founded: 1989 · Headquarters: Mountain View, US · Employees: N/A · Revenue: N/A · Market cap: N/A